NASDAQ OMX

Mining Rigs from Hminers Offering up to 650 TH/s Hash Power for Bitcoin Mining

Dela

Hminers is now creating waves in the global cryptocurrency market with their powerful mining rigs that are capable of delivering hash powers up to 650 TH/s of hash power for bitcoin mining. Offering guaranteed return on investment within a month, these mining rigs can also be used for mining Litecoin, Ethereum, or Dash.

MIAMI, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Hminers ( www.hminers.com ) looks all set to script an unprecedented success story in the worldwide industry for cryptocurrencies. The company's three mining rigs are quickly emerging as the most preferred option amongst thousands of bitcoin miners around the world. The most extraordinary feature of these mining rigs is their ability to deliver extremely high hash power, while keeping the power consumption under reasonable limits. These multi-algorithm mining rigs can be used to mine Bitcoin (hash power of up to 650 TH/s), Litecoin (hash power of up to 22.5 GH/s), Ethereum (hash power of up to 15 GH/s), and Dash (hash power of up to 50 GH/s).

Though the concept of cryptocurrency is now understood by many people around the world, the term cryptocurrency mining still remains to be relatively unknown. As far as the income perspective of cryptocurrency mining is concerned, hash rates are of prime importance. Functionally speaking, this is a measure of the power of the miner's hardware and reflects the hash function computation frequency per second. The performance of the miners is measured in MH/s (Mega hash per second), GH/s (Giga hash per second), and TH/s (Terra hash per second).

Hminers is a team of industry experts that hit the headlines in the past by designing and creating the world's first 10 nm ASIC Chip. Their three mining rigs H2U Miner, H4U Miner, and Rack Equipped with 5 x H4U were designed to ensure higher profitability for the users. This goal has been accomplished by maximizing the hash rate and minimizing the power consumption to a level that hasn't been achieved so far. Unlike any other similar product available on the market, Hminers has made it possible to mine multiple algorithms such as SHA-256, Scrypt, Etehash, and X11.

Some key features of the Bitcoin, Litecoin, and Ethereum miners from Hminers include:

  • Hash rate of up to 650 TH/s, 22.5 GH/s, 15 GH/s and 50 GH/s for Bitcoin, Litecoin, Ethereum and Dash, respectively.
  • Low power consumption, operating temperature, and noise
  • Guaranteed return on investment within a month
  • User-friendly with pre-installed software
  • Built and Designed to operate under multiple algorithm

Highlighting the superior qualities of these mining rigs, the CTO of Hminers, Benjamin Berglung stated, "Some of the biggest products available on the market offer 13TH with a power consumption of 1300W. We are offering much higher hash rates with the same power consumption."

To find out more about the new Hminers Mining Rigs, please visit https://hminers.com/products/.

About Hminers: Hminers is the most recognizable companies in the cryptocurrency industry and the proud creators of the world's first 10 nm ASIC Chip. The core team of this organization comprises of top level specialists from globally renowned organizations such as IBM, Microsoft, and Samsung.

Contact: 
Adam Lark 
info@hminers.com 
+1 305-203-6542



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hminers via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Umecrine Cognition announces first patient included in clinical Phase 2a study in patients with sleep disorder20.11.2017 08:00Pressmeddelande

STOCKHOLM - November 20, 2017. Umecrine Cognition AB, a Karolinska Development (Nasdaq Stockholm: KDEV) portfolio company, today announces the inclusion of the first patient in a clinical Phase 2a study with the lead compound GR3027 in patients with idiopathic hypersomnia. The objectives of the study (protocol UCAB-CT-03) are to assess the safety and pharmacokinetics, and to evaluate the exploratory efficacy of GR3027 in patients with idiopathic hypersomnia. Idiopathic hypersomnia (IH) is a severe orphan disease characterized by chronic excessive daytime sleepiness (EDS). It is a lifelong debilitating condition with a profound effect on the patient's quality of life. There are no approved treatments for IH but several wake-promoting treatments are used off-label. However, they are inadequate to alleviate symptoms in most patients, and medication-refractory symptoms or medication intolerance prevents control of symptoms in approximately one-quarter of IH patients.

Umecrine Cognition announces first patient included in clinical Phase 2a study in patients with sleep disorder20.11.2017 08:00Pressmeddelande

STOCKHOLM - November 20, 2017. Umecrine Cognition AB, a Karolinska Development (Nasdaq Stockholm: KDEV) portfolio company, today announces the inclusion of the first patient in a clinical Phase 2a study with the lead compound GR3027 in patients with idiopathic hypersomnia. The objectives of the study (protocol UCAB-CT-03) are to assess the safety and pharmacokinetics, and to evaluate the exploratory efficacy of GR3027 in patients with idiopathic hypersomnia. Idiopathic hypersomnia (IH) is a severe orphan disease characterized by chronic excessive daytime sleepiness (EDS). It is a lifelong debilitating condition with a profound effect on the patient's quality of life. There are no approved treatments for IH but several wake-promoting treatments are used off-label. However, they are inadequate to alleviate symptoms in most patients, and medication-refractory symptoms or medication intolerance prevents control of symptoms in approximately one-quarter of IH patients.

Integrum uppmärsammas av Frankrikes president Emmanuel Macron och Stefan Löfven17.11.2017 19:02Pressmeddelande

PRESSINFORMATION 17 november 2017                                  Integrum blev vid fredagens EU-toppmöte i Göteborg som ett av få inbjudna att presentera bolagets tankestyrda proteser för Frankrikes president Emmanuel Macron och Stefan Löfven. Detta i samband med det strategiska partnerskap för innovation mellan Frankrike och Sverige som undertecknades vid mötet med mål att presentera konkreta framsteg inom två år. Integrum var utvalt som ett bra exempel på innovativt företag som utvecklar avancerade medicintekniska produkter där samspelet mellan människa och teknik skapar stort värde för användaren. Under mötet med president Emmanuel Macron och Stefan Löfven demonstrerades Integrums världsunika proteser som styrs med hjälp av tankekraft. Tekniken möjliggör att personer kan få en protes direkt kopplat till skelett, nerver och muskler utan att ha elektroder tillfälligt fästa utanpå huden. "Det är självklart mycket hedrande att I

CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research17.11.2017 18:07Pressmeddelande

SANTA CLARA, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the launch of a grant program supporting oncology research scientists which provides funding for projects that show promise for scientific advancement of Patient Derived Xenograft (PDX) technology. Research Grants up to $50,000 will be awarded to projects focused on accelerating the pace of preclinical innovation and novel PDX methodologies that improve clinical predictions with sound science. The program offers an opportunity for investigators to receive funding for projects that may not receive support through traditional funding channels. Submitted proposals will be reviewed and selected by CrownBio's Scientific Steering Committee with the goa

Barings Backs Sentinel Capital Partners in Acquisition of Nekoosa17.11.2017 17:00Pressmeddelande

CHARLOTTE, N.C., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as Lead Agent on a senior secured credit facility to support Sentinel Capital Partners in its acquisition of Nekoosa ("Nekoosa" or the "Company"). Headquartered in Nekoosa, Wisconsin, the Company is a leading manufacturer of specialty paper and film products used in the graphics and commercial print markets, including application and pressure-sensitive tapes, specialty synthetic papers, sheeted digital and offset grade carbonless paper, and extruded film products. Nekoosa serves a highly diverse base of more than 70,000 commercial print and graphics shops in 65 countries. Barings served as lead senior lender on the transaction, which included a senior term loan and a revolving credit facility. "Sentinel is pleased to have Barings' support on our investment in Nekoosa," said Scott Perry, a partner with Sentinel Capital Partner

At SC17, ExaScaler and PEZY Computing Unveil Gyoukou Supercomputer with a High Combined Green500/Top500 Ranking16.11.2017 23:29Pressmeddelande

ExaScaler and PEZY Computing Also Take Top Three Green500 Positions DENVER, Nov. 16, 2017 (GLOBE NEWSWIRE) -- At SC17, ExaScaler and PEZY Computing unveiled their Gyoukou supercomputer whose Green500 and Top500 rankings attest to a unique combination of high efficiency and computing power. The Gyoukou supercomputer is installed at the Yokohama Research Institute in Japan. (Video: PEZY Liquid immersion cooling) PEZY supercomputers leverage 48V Factorized Power, a high efficiency, high density power distribution architecture. PEZY's CPUs are co-packaged with Vicor's Power-on-Package ("PoP") Modular Current Multipliers ("MCMs"), which enable efficient, direct 48V to sub-1V current multiplication at the XPU. ExaScaler and PEZY Computing also achieved the #1, #2 and #3 positions on the Green500. These supercomputer system installations also utilize 48V Factorized Power. Come see us at SC17 at Booth 633 where ExaScaler / PEZY Computing will be

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum